These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11469375)

  • 1. Comparative cost effectiveness supports the use of meningococcal vaccine in schools after a single case.
    Roberts RJ; Petrovic M
    J Public Health Med; 1999 Dec; 21(4):480-1. PubMed ID: 11469375
    [No Abstract]   [Full Text] [Related]  

  • 2. Meningitis B vaccine to be introduced in UK after U turn on its cost effectiveness.
    Wise J
    BMJ; 2014 Mar; 348():g2327. PubMed ID: 24665138
    [No Abstract]   [Full Text] [Related]  

  • 3. Should we be doing more to prevent Group C meningococcal infection in school age children? How can we decide?
    Johnstone T
    J Public Health Med; 1999 Dec; 21(4):480; author reply 481. PubMed ID: 11469376
    [No Abstract]   [Full Text] [Related]  

  • 4. The price of prevention: what now for immunisation against meningococcus B?
    Moxon R; Snape MD
    Lancet; 2013 Aug; 382(9890):369-370. PubMed ID: 23911365
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunisation against meningococcus B.
    Blewitt J
    Lancet; 2013 Sep; 382(9895):857-8. PubMed ID: 24012267
    [No Abstract]   [Full Text] [Related]  

  • 6. Costs, compassion, and the case for vaccination.
    Lancet Infect Dis; 2016 Apr; 16(4):385. PubMed ID: 27036333
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy, safety, and cost-effectiveness of meningococcal vaccines].
    Chinese Preventive Medicine Association
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Feb; 40(2):129-135. PubMed ID: 30744260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
    Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
    Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dutch consider following UK on vaccines after meningitis scare.
    Sheldon T
    BMJ; 2001 Sep; 323(7311):470. PubMed ID: 11532831
    [No Abstract]   [Full Text] [Related]  

  • 10. A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine.
    Robbins JB; Schneerson R; Gotschlich EC
    Pediatr Infect Dis J; 2000 Oct; 19(10):945-53. PubMed ID: 11055594
    [No Abstract]   [Full Text] [Related]  

  • 11. Meningococcal disease control in countries of the African meningitis belt, 2014.
    Wkly Epidemiol Rec; 2015 Mar; 90(13):123-31. PubMed ID: 25816448
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa.
    Miller MA; Wenger J; Rosenstein N; Perkins B
    Pediatr Infect Dis J; 1999 Dec; 18(12):1051-9. PubMed ID: 10608623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How college nurses managed the meningitis C campaign.
    Halligan E
    Nurs Times; 2000 Nov 30-Dec 6; 96(48):38-9. PubMed ID: 11965995
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mass vaccination campaign against serogroup C meningococcal disease, municipality of Itapeva, Sao Paulo].
    Centro de Vigilância Epidemiológica Prof. Alexandre Vranjac, Secretaria de Estado da Saúde de São Paulo
    Rev Saude Publica; 2005 Feb; 39(1):139-40. PubMed ID: 15654472
    [No Abstract]   [Full Text] [Related]  

  • 15. Leveraging community concerns regarding meningococcal disease to address racial and socioeconomic disparities in immunization coverage.
    Jones RC; Ramirez E; Gerber SI; Ritger KA; Morita JY
    J Public Health Manag Pract; 2011; 17(4):E3-8. PubMed ID: 21617399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is vaccination against meningitis useful? The findings of an investigation in the Sherbrooke region, Quebec.
    De Wals P; Allard MA; Guindon K; Mayrand L; Simard S; Black R
    Can Commun Dis Rep; 2002 Apr; 28(8):61-3. PubMed ID: 11974427
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemic meningitis control in countries of the African meningitis belt, 2016.
    Wkly Epidemiol Rec; 2017 Mar; 92(13):145-54. PubMed ID: 28361528
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeted vaccination of teenagers following continued rapid endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015.
    Campbell H; Saliba V; Borrow R; Ramsay M; Ladhani SN
    Euro Surveill; 2015 Jul; 20(28):. PubMed ID: 26212140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.
    Pace D; Pollard AJ
    Arch Dis Child; 2007 Oct; 92(10):909-15. PubMed ID: 17895339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of BC meningococcal vaccine in Brazil.
    Nishioka S
    Int J Epidemiol; 1996 Oct; 25(5):1102-3. PubMed ID: 8921501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.